STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1323 by analyst upside · 2026-06-27
KRMD
KORU Medical Systems, Inc.
Healthcare · Market Cap $205M · P/E 0x
ANALYST PRICE TARGET
+52.5%
implied upside to consensus target
Current Price $4.46
Consensus Target $6.8
Bull Target $8.0
Bear Target $5.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
1
Sell
0
52-Week Low $2.91
52-Week High $6.61
YTD Return -20.5%
FUNDAMENTALS
Market Cap $205M
P/E Ratio (TTM) N/A
Forward P/E 55.8x
EPS (TTM) $-0.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $43M
Profit Margin -5.3%
52-WEEK RANGE
52-Week Low $2.91
52-Week High $6.61
Current Price $4.46
Bear Target $5.0
Bull Target $8.0
● Now $4.46 ● Target $6.8
TRADING DATA
Avg Volume 130K
YTD Return -20.5%
Analyst Count 5
Consensus Buy
Upside to Target +52.5%
Last Updated 2026-06-27

ANALYST SUMMARY

KORU Medical Systems, Inc. (KRMD) is currently trading at $4.46 with a Wall Street consensus price target of $6.8, implying potential upside of 52.5% over the next 12 months. 5 analysts currently cover KRMD, with a consensus rating of Buy - 80% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $5.0.

KRMD operates in the Healthcare sector with a market capitalisation of $205M. The stock is down 20.5% year-to-date and is currently trading near the lower end of its 52-week range of $2.91 – $6.61.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for KRMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-03-13 Building track record
B. Riley Securities — Reiterated
Buy → Buy 2026-03-13 17% win rate (6 calls)
Lake Street — Reiterated
Buy → Buy 2025-12-22 27% win rate (11 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2025-12-17 Building track record
Piper Sandler — Reiterated
Neutral → Neutral 2025-08-07 14% win rate (7 calls)
Piper Sandler — Reiterated
Neutral → Neutral 2025-05-08 14% win rate (7 calls)
Piper Sandler ↓ Downgrade
Overweight → Neutral 2025-02-14 14% win rate (7 calls)
Craig-Hallum — Reiterated
Buy → Buy 2025-01-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
53
out of 100
Coverage depth
14/30
Consensus clarity
17/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →